Volume 73, Issue 2
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645


To assess mother-to-child transmission (MTCT) of hepatitis C virus (HCV) in Cameroon, 5,008 pregnant women were screened for HCV antibodies. Eighty-nine (1.8%) were HCV-antibody (HCV-Ab) positive. Among these, 7 (7.9%) were HBsAg positive, 6 (6.7%) HIV-positive, and one (1.1%) was co-infected by both hepatitis B virus (HBV) and HIV. Sixty-eight (76%) out of 89 HCV-Ab positive pregnant women were HCV-RNA positive. The HCV genotype determination indicated the predominance of genotype 4 (45.3%), followed by the genotypes 1 (28.1%) and 2 (26.6%). The mean HCV-RNA levels of 41 women at the time of delivery was 4.8 (range 0.06–34.7) × 10 RNA copies/mL. Finally, 35 women delivered 36 live children. None of those screened at 6 weeks and 6 months of age were HCV-RNA positive. The failure to detect HCV vertical transmission suggests that the mother-to-child transmission (MTCT) is not a major route of HCV transmission in Cameroon.


Article metrics loading...

Loading full text...

Full text loading...



  1. WHO, 1999. Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. J Viral Hepat 6 : 35–47.
  2. Boyer N, Marcellin P, 2000. Pathogenesis, diagnosis and management of hepatitis C. J Hepatol 32 : 98–112.
  3. Madhava V, Burgess C, Drucker E, 2002. Epidemiology of chronic hepatitis C virus infection in sub-Saharan Africa. Lancet Infect Dis 2 : 293–302.
  4. Memon M, Memon M, 2002. Hepatitis C: an epidemiological review. J Viral Hepat 9 : 84–100.
  5. Ceci O, Margiotta M, Marello F, Francavilla R, Loizzi P, Francavilla A, Mautone A, Impedovo L, Ierardi E, Mastroianni M, Bettocchi S, Selvaggi L, 2001. Vertical transmission of hepatitis C virus in a cohort of 2,447 HIV-seronegative pregnant women: a 24-month prospective study. J Pediatr Gastroenterol Nutr 33 : 570–575.
  6. Agha S, Sherif L, Allam M, Fawzy M, 1998. Transplacental transmission of hepatitis C virus in HIV-negative mothers. Res Virol 149 : 229–234.
  7. Conte D, Fraquelli M, Prati D, Colucci A, Minola E, 2000. Prevalence and clinical course of chronic hepatitis C virus (HCV) infection and rate of HCV vertical transmission in a cohort of 15,250 pregnant women. Hepatology 31 : 751–755.
  8. Kage M, Ogasawara S, Kosai K, Nakashima E, Shimamatsu K, Kojiro M, Kimura A, Fujisawa T, Matsukuma Y, Ito Y, Kondo S, Kawano K, Sata M, 1997. Hepatitis C virus RNA present in saliva but absent in breast-milk of the hepatitis C carrier mother. J Gastroenterol Hepatol 12 : 518–521.
  9. Roberts E, Yeung L, 2002. Maternal-infant transmission of hepatitis C virus infection. Hepatology 36 : S106–S113.
  10. Zanetti AR, Tanzi E, Newell ML, 1999. Mother-to-infant transmission of hepatitis C virus. J Hepatol 31 (Suppl 1): 96–100.
  11. Dal Molin G, D’Agaro P, Ansaldi F, Ciana G, Fertz C, Alberico S, Campello C, 2002. Mother-to-infant transmission of hepatitis C virus: rate of infection and assessment of viral load and IgM anti-HCV as risk factors. J Med Virol 67 : 137–142.
  12. Thomas S, Newell M, Peckham C, Ades A, Hall A, 1998. A review of hepatitis C virus (HCV) vertical transmission: risks of transmission to infants born to mothers with and without HCV viraemia or human immunodeficiency virus infection. Int J Epidemiol 27 : 108–117.
  13. Okamoto N, Murakami K, Iitsuka H, Matsuda T, Shiraki H, 2000. Prospective reevaluation of risk factors in mother-to-child transmission of hepatitis C virus: high virus load, vaginal delivery, and negative anti-NS4 antibody. J Infect Dis 182 : 1511–1514.
  14. Kumar R, Frossad P, Hughes P, 1997. Seroprevalence and mother-to-infant transmission of hepatitis C in asymptomatic Egyptian women. Eur J Obstet Gynecol Reprod Biol 75 : 177–182.
  15. Stoszek S, Fix A, Narooz S, El Kafrawy S, Saleh S, Kassern E, Hawash Y, Baligh H, El Henawy I, Thomas Strickland G, 2001. Mother-to-infant HCV transmission in a Nile Delta community: preliminary results. J Hepatol 34 : 165.
  16. Benjelloun S, Bahbouhi B, Sekkat S, Bennani A, Hda N, Benslimane A, 1996. Anti-HCV seroprevalence and risk factors of hepatitis C virus infection in Moroccan population groups. Res Virol 147 : 247–255.
  17. Kassem AS, el-Nawawy AA, Massoud MN, el-Nazar SY, Sobhi EM, 2000. Prevalence of hepatitis C virus (HCV) infection and its vertical transmission in Egyptian pregnant women and their newborns. J Trop Pediatr 46 : 231–233.
  18. Menendez C, Sanchez-Tapias J, Kahigwa E, Mshinda H, Costa J, Vidal J, Acosta C, Lopez-Labrador X, Olmedo E, Navia M, Tanner M, Rodes J, Alonso P, 1999. Prevalence and mother-to-infant transmission of hepatitis viruses B, C, and E in Southern Tanzania. J Med Virol 58 : 215–220.
  19. Ayouba A, Tene G, Cunin P, Foupouapouognigni Y, Menu E, Kfutwah A, Thonnon J, Scarlatti G, Monny-Lobe M, Eteki N, Kouanfack C, Tardy M, Leke R, Nkam M, Nlend A, Barre-Sinoussi F, Martin P, Nerrienet E, 2003. Low rate of mother-to-child transmission of HIV-1 after nevirapine intervention in a pilot public health program in Yaoundé, Cameroon. J Acquir Immune Defic Syndr 34 : 274–280.
  20. Vranckx R, Alisjahbana A, Meheus A, 1999. Hepatitis B virus vaccination and antenatal transmission of HBV markers to neonates. J Viral Hepat 6 : 135–139.
  21. Njouom R, Pasquier C, Ayouba A, Sandres-Saune K, Mfoupouendoun J, Mony Lobe M, Tene G, Thonnon J, Izopet J, Nerrienet E, 2003. Hepatitis C virus infection among pregnant women in Yaounde, Cameroon: Prevalence, viremia, and genotypes. J Med Virol 69 : 384–390.
  22. Takeuchi T, Katsume A, Tanaka T, Abe A, Inoue K, Tsukiyama-Kohara K, Kawaguchi R, Tanaka S, Kohara M, 1999. Real-Time detection system for quantification of hepatitis C Virus genome. Gastroenterology 116 : 636–205.
  23. Sandres-Saune K, Deny P, Pasquier C, Thibaut V, Duverlie G, Izopet J, 2003. Determining Hepatitis C genotype by analysing the sequence of NS5b region. J Virol Method 109 : 187–193.
  24. Thompson J, Gibson T, Plewniak F, Jeanmougin F, Higgins D, 1997. The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 25 : 4876–4882.
  25. Kumar S, Tamura K, Jakobsen IB, Nei M, 2001. MEGA2: molecular evolutionary genetics analysis software. Bioinformatics 17 : 1244–1245.
  26. Robertson B, Myers G, Howard C, Brettin T, Bukh J, Gaschen B, Gojobori T, Maertens G, Mizokami M, Nainan O, Netesov S, Nishioka K, Shini T, Simmonds P, Smith D, Stuyver L, Weiner A, 1998. Classification, nomenclature, and database development for hepatitis C virus (HCV) and related viruses: proposals for standardization. International Committee on Virus Taxonomy. Arch Virol 143 : 2493–2503.
  27. Njouom R, Pasquier C, Ayouba A, Gessain A, Froment A, Mfoupouendoun J, Pouillot R, Dubois M, Sandres-Saune K, Thonnon J, Izopet J, Nerrienet E, 2003. High rate of hepatitis C virus infection and predominance of genotype 4 among elderly inhabitants of a remote village of the rain forest of South Cameroon. J Med Virol 71 : 219–225.
  28. Trimoulet P, Halfon P, Pohier E, Khiri H, Chene G, Fleury H, 2002. Evaluation of the VERSANT HCV RNA 3.0 assay for quantification of hepatitis C virus RNA in serum. J Clin Microbiol 40 : 2031–2036.
  29. Ruggieri A, Argentini C, Kouruma F, Chionne P, D’Ugo E, Spada E, Dettori S, Sabbatani S, Rapicetta M, 1996. Heterogeneity of hepatitis C virus genotype 2 variants in West Central Africa (Guinea Conakry). J Gen Virol 77 : 2073–2076.
  30. Jeannel D, Fretz C, Traore Y, Kohdjo N, Bigot A, Pe Gamy E, Jourdan G, Kourouma K, Maertens G, Fumoux F, Fournel J, Stuyver L, 1998. Evidence for high genetic diversity and long-term endemicity of hepatitis C virus genotypes 1 and 2 in West Africa. J Med Virol 55 : 92–97.
  31. Candotti D, Temple J, Sarkodie F, Allain J-P, 2003. Frequent recovery and broad genotype 2 diversity characterize hepatitis C virus infection in Ghana, West Africa. J Virol 77 : 7914–7923.
  32. Rouet F, Chaix M, Inwoley A, Msellati P, Viho I, Combe P, Leroy V, Dabis F, Rouzioux C, 2004. HBV and HCV prevalence and viraemia in HIV-positive and HIV-negative pregnant women in Abidjan, Cote d’Ivoire: the ANRS 1236 study. J Med Virol 74 : 34–40.
  33. Laurent C, Henzel D, Mulanga-Kabeya C, Maertens G, Larouze B, Delaporte E, 2001. Seroepidemiological survey of hepatitis C virus among commercial sex workers and pregnant women in Kinshasa, Democratic Republic of Congo. Int J Epidemiol 30 : 872–877.
  34. Ahmed S, Cuevas L, Brabin B, Kazembe P, Broadhead R, Verhoeff F, Hart C, 1998. Seroprevalence of hepatitis B and C and HIV in Malawian pregnant women. J Infect 37 : 248–251.
  35. Ndumbe P, Skalsky J, Joller-Jemelka H, 1994. Seroprevalence of hepatitis and HIV infection among rural pregnant women in Cameroon. APMIS 102 : 662–666.
  36. Raghuraman S, Subramaniam T, Daniel D, Sridharan G, Abraham P, 2003. Occurrence of false positives during testing for antibodies to hepatitis C virus among volunteer blood donors in India. J. Clin. Microbiol. 41 : 1788–1790.
  37. Seeff L, 2002. Natural history of chronic hepatitis C. Hepatology 36 : S35–S46.
  38. Nkengasong J, Nyambi P, Claeys H, De Beenhouwer H, Collart J, Ayuk J, Ndumbe P, 1995. Predominantly hepatitis C virus genotypes 1 and 2 are found in Cameroon. J Infect Dis 171 : 1380–1381.
  39. Ndjomou J, Pybus OG, Matz B, 2003. Phylogenetic analysis of hepatitis C virus isolates indicates a unique pattern of endemic infection in Cameroon. J Gen Virol 84 : 2333–2341.
  40. Roudot-Thoraval F, Pawlotsky J, Thiers V, Deforges L, Girollet P, Guillot F, Huraux C, Aumont P, Brechot C, Dhumeaux D, 1993. Lack of mother-to-infant transmission of hepatitis C virus in human immunodeficiency virus-seronegative women: a prospective study with hepatitis C virus RNA testing. Hepatology 17 : 772–777.
  41. Marcellin P, Bernuau J, Martinot-Peignoux M, Larzul D, Xu L, Tran S, Bezeaud A, Guimont M, Levardon M, Aumont P, 1993. Prevalence of hepatitis C virus infection in asymptomatic anti-HIV1 negative pregnant women and their children. Dig Dis Sci 38 : 2151–2155.
  42. Reinus JF, Leikin EL, Alter HJ, Cheung L, Shindo M, Jett B, Piazza S, Shih JW, 1992. Failure to detect vertical transmission of hepatitis C virus. Ann Intern Med 117 : 881–886.
  43. Fischler B, Lindh G, Lindgren S, Forsgren M, Von Sydow M, Sangfelt P, Alaeus A, Harland L, Enockson E, Nemeth A, 1996. Vertical transmission of hepatitis C virus infection. Scand J Infect Dis 28 : 353–356.
  44. Pipan C, Amici S, Astori G, Ceci G, Botta G, 1996. Vertical transmission of hepatitis C virus in low-risk pregnant women. Eur J Clin Microbiol Infect Dis 15 : 116–120.
  45. Jabeen T, Cannon B, Hogan J, Crowley M, Devereux C, Fanning L, Kenny-Walsh E, Shanahan F, Whelton MJ, 2000. Pregnancy and pregnancy outcome in hepatitis C type 1b. QJM 93 : 597–601.
  46. Tao Y, Cao Y, 1993. Modulation of interferon secretion by concanavalin A and interleukin-2 in first trimester placental explants in vitro. J Reprod Immunol 24 : 201–212.
  47. Chard T, Craig P, Menabawey M, Lee C, 1986. Alpha interferon in human pregnancy. Br J Obstet Gynaecol 93 : 1145–1149.
  48. Duc-Goiran P, Chany C, Doly J, 1989. Unusually large interferon-alpha-like mRNAs and high expression of interleukin-6 in human fetal annexes. J Biol Chem 264 : 16507–16511.
  49. Eyster M, Diamondstone L, Lien J, Ehmann W, Quan S, Goedert J, 1993. Natural history of hepatitis C virus infection in multi-transfused hemophiliacs: effect of coinfection with human immunodeficiency virus. The Multicenter Hemophilia Cohort Study. J Acquir Immune Defic Syndr 6 : 602–610.
  50. Sagnelli E, Coppola N, Messina V, Di Caprio D, Marrocco C, Marotta A, Onofrio M, Scolastico C, Filippini P, 2002. HBV superinfection in hepatitis C virus chronic carriers, viral interaction, and clinical course. Hepatology 36 : 1285–1291.
  51. Gervais A, Bacq Y, Bernuau J, Martinot M, Auperin A, Boyer N, Kilani A, Erlinger S, Valla D, Marcellin P, 2000. Decrease in serum ALT and increase in serum HCV RNA during pregnancy in women with chronic hepatitis C. J Hepatol 32 : 293–299.
  52. Guay L, Musoke P, Fleming T, Bagenda D, Allen M, Nakabiito C, Sherman J, Bakaki P, Ducar C, Deseyve M, Emel L, Mirochnick M, Fowler M, Mofenson L, Miotti P, Dransfield K, Bray D, Mmiro F, Jackson J, 1999. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet 354 : 795–802.
  53. Hershow R, Riester K, Lew J, Quinn T, Mofenson L, Davenny K, Landesman S, Cotton D, Hanson I, Hillyer G, Tang H, Thomas D, 1997. Increased vertical transmission of human immunodeficiency virus from hepatitis C virus-coinfected mothers. Women and Infants Transmission Study. J Infect Dis 176 : 414–420.
  54. Mwapasa V, Rogerson S, Molyneux M, Abrams E, Kamwendo D, Lema V, Tadesse E, Chaluluka E, Wilson P, Meshnick S, 2004. The effect of Plasmodium falciparum malaria on peripheral and placental HIV-1 RNA concentrations in pregnant Malawian women. AIDS 18 : 1051–1059.
  55. Xiao L, Owen S, Rudolph D, Lal R, Lal A, 1998. Plasmodium falciparum antigen-induced human immunodeficiency virus type 1 replication is mediated through induction of tumor necrosis factor-alpha. J Infect Dis 177 : 437–445.
  56. Ayouba A, Nerrienet E, Menu E, Lobe MM, Thonnon J, Leke RJ, Barre-Sinoussi F, Martin P, Cunin P, 2003. Mother-to-child transmission of human immunodeficiency virus type 1 in relation to the season in Yaoundé, Cameroon. Am J Trop Med Hyg 69 : 447–449.

Data & Media loading...

  • Received : 09 Mar 2005
  • Accepted : 29 Mar 2005

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error